In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
about
Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study.In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studiesIn vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, anBactericidal activities of antibiotics against intracellular Francisella tularensis.Macrolide resistance conferred by base substitutions in 23S rRNA.Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebaeControlled trial of a 5-day course of telithromycin versus doxycycline for treatment of mild to moderate scrub typhusEffects of Escherichia coli lipopolysaccharide on telithromycin pharmacokinetics in rats: inhibition of metabolism via CYP3A.Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumoniaTelithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J miceIn vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (Telithromycin) against Chlamydia pneumoniaeIn vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.In vitro susceptibilities of Chlamydia pneumoniae isolates from German patients and synergistic activity of antibiotic combinationsEffect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin.Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers.
P2860
Q24813259-BB4A65E8-6FFF-4F3C-A4B7-823D89237E1FQ28344762-E6A4BBAE-BB9E-4D14-8728-D21F85CD8298Q30662421-181B0947-D8DC-4530-8ECD-04C6989FD7EEQ33676151-7DED7F3C-8F30-49A8-9B98-079336B24F5DQ33905858-4C3DB753-F3D7-4662-B28F-7C927F50B2C5Q33979566-07B7BB6A-EB2C-48F7-A941-DFC014F24766Q33981024-C1549667-2545-495A-8774-6809F894FC7CQ34106180-C14FB166-7EBA-4D3B-855B-DC3DB385A2DDQ34112665-0DA83013-CA4B-45D9-A2A8-E5237628FC15Q35840827-23621F78-FA97-4924-80B1-DAE0E8F73BB3Q36482873-25B6FB53-6986-41B7-A5E8-DA7C6CB9097EQ37116814-D9941EDE-5F7A-43B4-B499-12A78B21DB49Q37568474-42D39C04-4B66-46CD-BC2F-922A3A30F053Q37876245-A1E8CC68-5F6F-4290-8B74-E8A45C64CD2BQ37876885-6AD32B74-60E6-47E0-82C8-A68F9199BDC3Q37878178-C0C92AC6-FE70-4064-A9F4-CF2E26827120Q39651581-5D99F26E-7A90-48FC-98F4-8FB203918489Q39652910-D44E0C5E-EEA7-49FC-B573-C0002A2197FD
P2860
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
@en
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
@nl
type
label
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
@en
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
@nl
prefLabel
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
@en
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
@nl
P2860
P356
P1476
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae
@en
P2093
M R Hammerschlag
P M Roblin
P2860
P304
P356
10.1128/AAC.42.6.1515
P407
P577
1998-06-01T00:00:00Z